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DiabetesAbstract The present study is characterized toward thespesone isolation from Thespesia populnea
(Malvaceae). Subsequently it was modified and characterized to study its effect on diabetes related
symptoms. The complex is administered to diabetes induced mice with the doses of 5, 10 and 20 mg/
kg, p.o. and the effect of complex on the level of body weight, lipid profile and blood glucose was
studied after 22 days. The results have indicated that diabetic mice show a significant (p< 0.01)
decrease in the level of serum triglyceride, plasma glucose and increase in body weight. Hence
the present investigation reveals that newly synthesized complex is useful in the management of
Type-II diabetes mellitus because of its ability to reduce insulin resistance.
Crown Copyright  2015 Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Diabetes is the most common disease as far as metabolic disor-
der is concerned, its incidence in the year 2010 was 210 million
and by 2025 it is proposed to increase to 300 million (Patel
et al., 2013). Diabetes mellitus is divided into two types,Type-I and Type-II. Type-II diabetes, however, is also called
non-insulin dependent diabetes mellitus, it develops on the
root of impaired insulin secretion or increased insulin resis-
tance (Kuzuya et al., 2002). The use of synthetic drugs might
be connected with unnecessary side effects, including hypo-
glycemia and cell death, which are effective in increasing insu-
lin secretion (Giorgino et al., 2006). Hence, there is an
increased scope to develop more safe, effective and cheap
methods for its treatment. It is a body’s condition where tis-
sues turn resistant to insulin, which results in an evident reduc-
tion of glucose metabolism in response to insulin. Recent
studies also suggest that insulin resistance results from com-
plex interactions between genetic and environmental factors
and is associated with common diseases such as Type-II
diabetes, hypertension, obesity and coronary artery disease
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focusing on target based treatment. Piroxicam proliferative
activated receptors, glucagon like peptide hormone b3-
Adenoreceptor agonist, DPP-IV inhibitors, a-lipoic acid, liver
selective glucocorticoid antagonist, PTB-1B inhibitors, glyco-
gen synthase kinase involved in glycogen metabolism,
fructose-1, 6-biphosphate as a therapeutic target for Type-II
diabetes are the new approaches in the treatment of diabetes
mellitus (Patel et al., 2013).
Vanadium is a trace elementwhich is essential for livingorgan-
isms (Miroslaw et al., 2013). The insulin-like properties of Vana-
dium provide standard diet which has acknowledged cationic
type vanadyl into its anionic type vanadate,which is concentrated
in cells. So, vanadyl sulfate used as a choice for the treatment of
management of diabetes is linked to their hyperinsulinemic, anti-
hyperglycemic and anti hyperlipidemic effects (Ali, 2012). In tra-
ditional systems, plants are proven to be a good source of herbal
medicine for the treatment of diabetes mellitus. Advances in dif-
ferent areas of plant investigation initiated fromextraction proce-
dures then isolation, identification, confirmation, design and
utilization of bio-assay for efficacy testing, dosage form design,
and study of pharmacodynamic, pharmacokinetic, toxicological
and pharmacological mode of action (Banerjee andMitra, 2012).
Thespesia populnea belonging to the family Malvaceae has been
recommended as an anti-diabetic agent in Ayurvedic Pharma-
copoeia of India (Anonymous, 2006). The various experimental
findings reveal that T. populnea elicited a wide spectrum of activ-
itiesmainlyAntibacterial activity (GaindandBapna, 1967),Anti-
Hepatotoxic activity (Shirwaiikar et al., 1995), Antisteroidogenic
activity (Kavimani et al., 1999), Cytotoxicity and superoxide
anion generation (Inbaraj et al., 1999), Antinociceptive and
anti-inflammatory activities (Vasudevan et al., 2007), Anti-
psoriatic activity (Shrivastav et al., 2009),Wound healing activity
(Nagappa and Binu, 2001), Dermatitis (Hausen et al., 1997),
Anti-oxidant activity (Ilavarasan et al., 2003), Alzheimer’s Dis-
ease (Vasudevan and Parle, 2006), Antidiabetic activity
(Parthasarathy et al., 2009), Synergistic activity (Vasudevan
and Sivakumar, 2009), Hypoglycemic, anti-diabetic and anti-
ulcer activities (Jayakumari et al., 2003), Immunomodulatory
activity (GaikwadandMohan, 2011),Anti-inflammatoryactivity
(Shah and Alagawadi, 2011), a-Amylase Inhibitory Activity
(Sangeetha and Vedasree, 2012), antiulcer activity (Patil et al.,
2010), Antioxidant and anti inflammatory activities (Sarma
et al., 2011), Memory-Enhancing activity (Vasudevan and
Parle, 2007).
In view of modern studies of phytochemistry, the modified
complex of isolated phytochemical constituent exhibits better
efficacy and activity. Therefore, the existing research work is
aimed at identifying the combined effect of isolated compound
thespesone (plant source) and Vanadium (mineral source) on
diabetic experimental mice.
2. Experimental
2.1. Plant collection
The dry bark of T. populnea was collected from a nearby area
of Pune, Maharashtra, India. The plant material is authenti-
cated from the Botanical Survey of India with voucher speci-
men conserved under reference number BSI/WRC/
Herbarium/2011.2.1.1. Extraction of bark and isolation of compound
The air dried finely powdered bark was extracted by soxhlet
extraction process with 90% hexane, then isolation of the
sesquiterpene by using column chromatography with solvent
system. The yield was found to be 10% after recrystallization
with ethanol.
2.1.2. General procedure for synthesis of its metal complex
The isolated compound forms a complex with Vanadium in
alkaline condition (Sodium acetate 30 mg) with methanolic
solutions of Vanadyl sulfate and the respective ligand in 1:2
(metal:ligand). The reaction mixture was stirred for 6 h at
room temperature. The precipitated metal complex was col-
lected by filtration, washed with cold methanol to get pure
complex.
2.2. Characterization of isolated thespesone and modified metal
complex
2.2.1. Infrared spectroscopy (IR)
Infrared spectra were recorded using KBr pellets on a Shi-
madzu 8400S infrared spectrophotometer to know the func-
tional groups present in thespesone and Vanadium complex
at the laboratory of Modern College of Pharmacy, Pune
(Donald et al., 2007; Sharma, 1980).
2.2.2. Electronic absorption spectroscopy
Electronic absorption spectra were recorded on a Shimadzu
1701 UV–VIS spectrophotometer using a matched pair of
1 cm2 quartz cells at the laboratory of Modern College of
Pharmacy, Pune (Donald et al., 2007; Sharma, 1980).
2.2.3. Nuclear magnetic resonance spectroscopy
Proton NMR spectra were measured on a Perkin Elmer instru-
ment Chemistry Department, University of Pune, operating at
300 MHz in CDCl3 solvent (Donald et al., 2007; Sharma,
1980).
2.2.4. Mass spectroscopy (MS)
The MS analysis of isolated compound was carried out on a
API 4000 (Triple Quadruple) using direct Infusion technique
in the split mode with scan Type: Q1 MS (Q1) and Ion Spray
Voltage is 4200 (Donald et al., 2007; Sharma, 1980).
2.2.5. Electron paramagnetic resonance spectroscopy (EPR)
The electron spin resonance studies of all the Vanadium com-
plexes were recorded at 77 K on a Varian X-band spectrometer
at the Regional Sophisticated Instruments Center (RSIC),
Indian Institute of Technology (IIT) Pavai, Mumbai, India.
2.3. Animals and experimental protocols
The study protocol was approved in accordance with the eth-
ical recommendations of animal experimentation protocol
(Certificate no: MCP/IAEC/46/2011). The animals had free
access to standard pellet (Amrut feeds, Bombay), with water
supplied under strict hygienic conditions. The Swiss albino
mice weighing 20–30 g were acclimatized for seven days under
standard husbandry conditions i.e. room temperature of 25 C;
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college of Pharmacy, Pune, Maharashtra, India.
2.4. Acute toxicity study (OECD, 2001)
The acute toxicity study for complex was performed using
albino mice followed by OECD 2001 guidelines. The animals
were fasted over-night prior to the experiment and maintained
under standard conditions.
2.5. Induction of diabetes
To induce diabetes in mice, a single intramuscular injection of
Dexamethasone at dose 1 mg/kg/day (Cadila Healthcare Ltd.,
India) was given to overnight fasted mice from day 1 to 7.
2.6. Dexamethasone induced insulin resistance in mice (Shalam
et al., 2006; Gholap and Kar, 2005).
The overnight fasted animals were divided into groups (n= 6)
as follows, Animals of Group-I received 1% gum acacia (1 ml/
kg/day, p.o.) from day 1 to 22. Animals of Group-II received
Dexamethasone (1 mg/kg/day, i.m.) from day 1 to 22. Animals
of Group-III, IV, V, VI, VII, VIII received Dexamethasone
(1 mg/kg/day, i.m.) from day 1 to 7 and Ketoconazole
(24 mg/kg/day, p.o), Pioglitazone (2 mg/kg/day, p.o), LVa
complex (5 mg/kg/day, p.o.), LVa complex (10 mg/kg/day, p.
o.), LVa complex (20 mg/kg/day, p.o), Va (0.2 mM/kg/day,
p.o.) from day 8 to 22, respectively.
2.6.1. Biochemical parameters
Diabetic animals were weighed before and after drug treat-
ment. On the 22nd day blood was withdrawn by puncturing
retro-orbital plexus by using fine glass capillary and collectedFigure 1 Infrared spectra of synand further it was used for the estimation of glucose and
triglyceride. Biochemical estimation of plasma glucose
(GOD/POD Method) and serum triglyceride (GPO/POD
Method) was done by using standard diagnostic kits.
2.7. Result interpretation by statistical analysis
The results are expressed as mean ± SEM and statistically
analyzed by Analysis of Variance (ANOVA) followed by Dun-
nett test, with level of significance set at p< 0.05, **p< 0.01.3. Result and discussion
3.1. Characterization of isolated thespesone and modified metal
complex
The compound (Thespesone) molecular formula is C15H14O4.
The Infrared spectrum of synthesized Vanadium complex seen
at different frequencies like OH at 3410.26 and C‚C at
1610.61 and the spectra of Vanadium complex are given in
Fig. 1. The Electronic absorption spectra of compound were
carried out by using DMSO solvent, kmax was found to be
289. The NMR signal of the CH2 group appears at d 1.70
of B ring and 2.38 of A ring. d 3.24 of B ring, d 4.69 and
d 4.57 in C ring. The CH3 group appears at d 1.48 of C
ring, signal of the CH group in C ring appears at d 4.28
and aromatic proton of A ring appears at d 6.94 and Mass
Spectroscopy analysis of isolated compound shows at m/z
258.2 it confirms the identity structure of Thespesone
(Donald et al., 2007; Sharma, 1980).
The EPR spectra of the Vanadium complex provided infor-
mation on metal ion environment and the electron delocaliza-
tion (Table 1). The X-band EPR spectra of Vanadium
complex, were recorded in DMSO glass at 77 K. The fourthesized Vanadium complex.
Table 1 Electron paramagnetic resonance parameters (at
77 K in DMSO glass) for Vanadium complexes (at 300 K).
LVa–Thespesone–Vanadium complex.
Compound gk g\ A F (cm
1)
LVa 1.99 1.98 190 106
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indicative of monomeric and Vanadium complex which gives
conformation about the complex.
3.2. Acute toxicity study
From acute toxicity study it was found that the Vanadium
complex was found safe up to a dose of 100 mg/kg, orally.
3.3. Dexamethasone induced insulin resistance in mice
In the adipocyte tissue glucocorticoids induce the ob gene
expression within 24 h then followed by multifaceted metabolicFigure 2 Effect of Vanadium complex on the body weight in Dexam
± SEM. (n= 6), ANOVA followed by Dunnett test. ##p< 0.01 when
Dexa-control.
Figure 3 Effect of Vanadium complex on plasma glucose in Dexame
± SEM. (n= 6), ANOVA followed by Dunnett test. ##p< 0.01 when
Dexa-control.changes resulting in fall of body weight, decline in food con-
sumption, usually accompanied by diabetes and the develop-
ment of insulin resistance along with increased blood glucose
and triglyceride level. Different mechanisms for corticosteroids
have been advocated for the increase in glucose level, one of
them being insulin resistance caused by the altered binding
of insulin receptors (Shalam et al., 2006; Gholap and Kar,
2005). Ketoconazole is an anti-glucocorticoid drug mainly,
which inhibits the synthesis of cortisol and it prevents insulin
resistance activity of dexamethasone (Storlien et al., 1992).
In the skeletal muscle, glucocorticoids reduce the rate of
basal and insulin-stimulated glucose uptake, although the
chronic accumulation of glycogen is improved.
Glucocorticoid-induced insulin resistance is credited mainly
to a post-receptor failing of insulin action, but this does not
decrease the insulin-sensitive glucose transporter isoform
GLUT 4 mRNA or GLUT 4 abundance in muscle membranes
(Thomas et al., 1998).
The development of non insulin dependent diabetes melli-
tus was characterized by increased insulin resistance and fail-
ure of normal b-cell activity resulting in a slow decrease inethasone induced insulin resistance. Values are expressed as mean
compared with control; *p< 05, **p< 0.01 when compared with
thasone induced insulin resistance. Values are expressed as mean
compared with control; *p< 05, **p< 0.01 when compared with
Figure 4 Effect of Vanadium complex on serum triglyceride in Dexamethasone induced insulin resistance. Values are expressed as mean
± SEM. (n= 6), ANOVA followed by Dunnett test. ##p< 0.01 when compared with control; *p< 05, **p< 0.01 when compared with
Dexa-control.
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Vanadium is an essential element which converted cationic
type vanadyl into its anionic type vanadate in cells. Vanadate
as a potent inhibitor of Na+–K+ ATPase increases the release
of insulin from the pancreatic b-cells (Crans et al., 1995) and
stimulates GTUT 4 so that glucose transport across the cell
increases (Brichard and Henquin, 1995).
In the present study, dexamethasone administered for
22 days produced significant increase in blood glucose and
triglyceride level. The treatment with Keto, Pio and different
doses of Vanadium complex prevented the rise in plasma
glucose due to dexamethasone (Figs. 3 and 4). The anti-
hyperglycemic activity of Vanadium complex in dexametha-
sone treated animals appears to be mediated by decreasing
the peripheral insulin resistance or by suppressing enzymes
involved in hepatic gluconeogenesis or by stimulating glucose
uptake in the peripheral tissues (Gholap and Kar, 2005).
There was a decrease in relative body weight of the diabetic
mice compared to control mice (Fig. 2). Treatment of dia-
betic mice with Vanadium complex increases the reduced
body weight by altering gluconeogenesis, glycolysis preven-
tion, lipolysis and causing an imbalance in lipid metabolism.
The plant T. populnea is also reported to have hepatoprotec-
tive activity. Thus in the present study the antihyperlipi-
demic activity of the Vanadium complex in dexamethasone
treated animal is likely to be mediated by decreasing the
lipolysis due to its antioxidant and hepatoprotective activi-
ties (Ghosh and Bhattacharya, 2004), also plays a role in
the stimulatory action of Vanadium complex on glucose
uptake.
4. Conclusions
In the results of the present study, it was observed that the
Vanadium complex found may prove to be useful in the treat-
ment of diabetes mellitus probably by overcoming the insulin
resistance. Further, Vanadium complex also prevents the pro-
gressive increase in glucose and triglyceride level and decrease
in body weight caused by dexamethasone. Complex may sig-
nificantly increase glucose uptake, which indicates that there
was boost in the insulin sensitivity.Conflicts of interest
There is no conflict of interest relevant to this article.
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